Listed

Sabra Health Care REIT, Inc.

SBRANasdaqCIK 1492298Real estateFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$128.8m, Q2 FY2026
Net income−$25.2m, Q2 FY2026
Sabra Health Care REIT, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m59.7Revenue, Q3 FY2023, three months to 2023-09-30$59.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure61.3Revenue, Q4 FY2023, three months to 2023-12-31$61.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure66.0Revenue, Q1 FY2024, three months to 2024-03-31$66.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure67.9Revenue, Q2 FY2024, three months to 2024-06-30$67.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure73.7Revenue, Q3 FY2024, three months to 2024-09-30$73.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure76.9Revenue, Q4 FY2024, three months to 2024-12-31$76.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure77.4Revenue, Q1 FY2025, three months to 2025-03-31$77.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure79.0Revenue, Q2 FY2025, three months to 2025-06-30$79.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure92.0Revenue, Q3 FY2025, three months to 2025-09-30$92.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure108Revenue, Q4 FY2025, three months to 2025-12-31$108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure117Revenue, Q1 FY2026, three months to 2026-03-31$116.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure129Revenue, Q2 FY2026, three months to 2026-06-30$128.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Income tax$m0.5Income tax, Q3 FY2023, three months to 2023-09-30$455.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure0.5Income tax, Q4 FY2023, three months to 2023-12-31$493.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.5Income tax, Q1 FY2024, three months to 2024-03-31$453.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure0.4Income tax, Q2 FY2024, three months to 2024-06-30$437.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure(0.3)Income tax, Q3 FY2024, three months to 2024-09-30−$265.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure0.4Income tax, Q4 FY2024, three months to 2024-12-31$380.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2025, three months to 2025-03-31$413.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure0.5Income tax, Q2 FY2025, three months to 2025-06-30$497.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure0.4Income tax, Q3 FY2025, three months to 2025-09-30$436.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure0.5Income tax, Q4 FY2025, three months to 2025-12-31$491.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.5Income tax, Q1 FY2026, three months to 2026-03-31$526.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure0.7Income tax, Q2 FY2026, three months to 2026-06-30$678.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Net income$m(15.1)Net income, Q3 FY2023, three months to 2023-09-30−$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure17.2Net income, Q4 FY2023, three months to 2023-12-31$17.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure26.3Net income, Q1 FY2024, three months to 2024-03-31$26.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure24.0Net income, Q2 FY2024, three months to 2024-06-30$24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure29.8Net income, Q3 FY2024, three months to 2024-09-30$29.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure46.7Net income, Q4 FY2024, three months to 2024-12-31$46.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure40.3Net income, Q1 FY2025, three months to 2025-03-31$40.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure65.5Net income, Q2 FY2025, three months to 2025-06-30$65.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure22.5Net income, Q3 FY2025, three months to 2025-09-30$22.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure27.2Net income, Q4 FY2025, three months to 2025-12-31$27.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure40.9Net income, Q1 FY2026, three months to 2026-03-31$40.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure(25.2)Net income, Q2 FY2026, three months to 2026-06-30−$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Diluted EPS$ per share(0.07)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figurenot reported0.11Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure0.10Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure0.13Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figurenot reported0.17Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure0.27Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure0.09Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figurenot reported0.16Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure(0.10)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Basic EPS$ per share(0.07)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figurenot reported0.11Basic EPS, Q1 FY2024, three months to 2024-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure0.10Basic EPS, Q2 FY2024, three months to 2024-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure0.13Basic EPS, Q3 FY2024, three months to 2024-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figurenot reported0.17Basic EPS, Q1 FY2025, three months to 2025-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure0.28Basic EPS, Q2 FY2025, three months to 2025-06-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure0.09Basic EPS, Q3 FY2025, three months to 2025-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figurenot reported0.16Basic EPS, Q1 FY2026, three months to 2026-03-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure(0.10)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure

Balance sheet

Cash and equivalents$231.6m, Q2 FY2026
Long-term debt$2.63bn, Q2 FY2026
Shareholders' equity$2.75bn, Q2 FY2026
Sabra Health Care REIT, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m33.3Cash and equivalents, Q3 FY2023, at 2023-09-30$33.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001492298-23-000025.Report this figure41.3Cash and equivalents, FY2023, at 2023-12-31$41.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure59.9Cash and equivalents, Q1 FY2024, at 2024-03-31$59.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001492298-24-000014.Report this figure36.4Cash and equivalents, Q2 FY2024, at 2024-06-30$36.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001492298-24-000025.Report this figure63.0Cash and equivalents, Q3 FY2024, at 2024-09-30$63.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure60.5Cash and equivalents, FY2024, at 2024-12-31$60.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure22.7Cash and equivalents, Q1 FY2025, at 2025-03-31$22.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure95.2Cash and equivalents, Q2 FY2025, at 2025-06-30$95.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure201Cash and equivalents, Q3 FY2025, at 2025-09-30$200.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure71.5Cash and equivalents, FY2025, at 2025-12-31$71.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure117Cash and equivalents, Q1 FY2026, at 2026-03-31$116.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure232Cash and equivalents, Q2 FY2026, at 2026-06-30$231.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Total assets$m5,381Total assets, Q3 FY2023, at 2023-09-30$5.38bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001492298-23-000025.Report this figure5,386Total assets, FY2023, at 2023-12-31$5.39bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure5,374Total assets, Q1 FY2024, at 2024-03-31$5.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001492298-24-000014.Report this figure5,351Total assets, Q2 FY2024, at 2024-06-30$5.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001492298-24-000025.Report this figure5,366Total assets, Q3 FY2024, at 2024-09-30$5.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure5,304Total assets, FY2024, at 2024-12-31$5.30bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure5,233Total assets, Q1 FY2025, at 2025-03-31$5.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure5,328Total assets, Q2 FY2025, at 2025-06-30$5.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure5,565Total assets, Q3 FY2025, at 2025-09-30$5.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure5,493Total assets, FY2025, at 2025-12-31$5.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure5,591Total assets, Q1 FY2026, at 2026-03-31$5.59bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure5,513Total assets, Q2 FY2026, at 2026-06-30$5.51bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Total liabilities$m2,512Total liabilities, Q3 FY2023, at 2023-09-30$2.51bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001492298-23-000025.Report this figure2,584Total liabilities, FY2023, at 2023-12-31$2.58bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure2,607Total liabilities, Q1 FY2024, at 2024-03-31$2.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001492298-24-000014.Report this figure2,589Total liabilities, Q2 FY2024, at 2024-06-30$2.59bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001492298-24-000025.Report this figure2,621Total liabilities, Q3 FY2024, at 2024-09-30$2.62bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure2,562Total liabilities, FY2024, at 2024-12-31$2.56bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure2,531Total liabilities, Q1 FY2025, at 2025-03-31$2.53bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure2,617Total liabilities, Q2 FY2025, at 2025-06-30$2.62bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,738Total liabilities, Q3 FY2025, at 2025-09-30$2.74bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure2,670Total liabilities, FY2025, at 2025-12-31$2.67bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure2,803Total liabilities, Q1 FY2026, at 2026-03-31$2.80bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure2,760Total liabilities, Q2 FY2026, at 2026-06-30$2.76bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Long-term debt$m2,349Long-term debt, Q3 FY2023, at 2023-09-30$2.35bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-06, accession 0001492298-23-000025.Report this figure2,414Long-term debt, FY2023, at 2023-12-31$2.41bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-02-27, accession 0001492298-24-000008.Report this figure2,463Long-term debt, Q1 FY2024, at 2024-03-31$2.46bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-08, accession 0001492298-24-000014.Report this figure2,447Long-term debt, Q2 FY2024, at 2024-06-30$2.45bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-07, accession 0001492298-24-000025.Report this figure2,470Long-term debt, Q3 FY2024, at 2024-09-30$2.47bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure2,418Long-term debt, FY2024, at 2024-12-31$2.42bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure2,394Long-term debt, Q1 FY2025, at 2025-03-31$2.39bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure2,480Long-term debt, Q2 FY2025, at 2025-06-30$2.48bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,591Long-term debt, Q3 FY2025, at 2025-09-30$2.59bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure2,529Long-term debt, FY2025, at 2025-12-31$2.53bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure2,665Long-term debt, Q1 FY2026, at 2026-03-31$2.67bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure2,626Long-term debt, Q2 FY2026, at 2026-06-30$2.63bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Shareholders' equity$m2,869Shareholders' equity, Q3 FY2023, at 2023-09-30$2.87bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure2,803Shareholders' equity, FY2023, at 2023-12-31$2.80bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,767Shareholders' equity, Q1 FY2024, at 2024-03-31$2.77bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,762Shareholders' equity, Q2 FY2024, at 2024-06-30$2.76bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,745Shareholders' equity, Q3 FY2024, at 2024-09-30$2.74bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure2,741Shareholders' equity, FY2024, at 2024-12-31$2.74bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure2,702Shareholders' equity, Q1 FY2025, at 2025-03-31$2.70bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,711Shareholders' equity, Q2 FY2025, at 2025-06-30$2.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure2,825Shareholders' equity, Q3 FY2025, at 2025-09-30$2.82bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure2,822Shareholders' equity, FY2025, at 2025-12-31$2.82bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure2,786Shareholders' equity, Q1 FY2026, at 2026-03-31$2.79bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure2,751Shareholders' equity, Q2 FY2026, at 2026-06-30$2.75bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure

Cash flow

Operating cash flow$85.8m, Q2 FY2026
Sabra Health Care REIT, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m83.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$83.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001492298-24-000031. Derived: 9-month figure less the 6-month figure.Report this figure78.7Operating cash flow, Q4 FY2023, three months to 2023-12-31$78.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure52.8Operating cash flow, Q1 FY2024, three months to 2024-03-31$52.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure80.1Operating cash flow, Q2 FY2024, three months to 2024-06-30$80.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-04, accession 0001492298-25-000031. Derived: 6-month figure less the 3-month figure.Report this figure97.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$97.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001492298-25-000039. Derived: 9-month figure less the 6-month figure.Report this figure80.0Operating cash flow, Q4 FY2024, three months to 2024-12-31$80.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure80.3Operating cash flow, Q1 FY2025, three months to 2025-03-31$80.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure81.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$81.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001492298-26-000028. Derived: 6-month figure less the 3-month figure.Report this figure100.0Operating cash flow, Q3 FY2025, three months to 2025-09-30$100.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001492298-25-000039. Derived: 9-month figure less the 6-month figure.Report this figure87.4Operating cash flow, Q4 FY2025, three months to 2025-12-31$87.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure98.4Operating cash flow, Q1 FY2026, three months to 2026-03-31$98.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure85.8Operating cash flow, Q2 FY2026, three months to 2026-06-30$85.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001492298-26-000028. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m69.4Dividends paid, Q3 FY2023, three months to 2023-09-30$69.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-10-31, accession 0001492298-24-000031. Derived: 9-month figure less the 6-month figure.Report this figure69.4Dividends paid, Q4 FY2023, three months to 2023-12-31$69.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure69.4Dividends paid, Q1 FY2024, three months to 2024-03-31$69.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure69.5Dividends paid, Q2 FY2024, three months to 2024-06-30$69.5m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-04, accession 0001492298-25-000031. Derived: 6-month figure less the 3-month figure.Report this figure70.3Dividends paid, Q3 FY2024, three months to 2024-09-30$70.3m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-05, accession 0001492298-25-000039. Derived: 9-month figure less the 6-month figure.Report this figure71.0Dividends paid, Q4 FY2024, three months to 2024-12-31$71.0m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure71.4Dividends paid, Q1 FY2025, three months to 2025-03-31$71.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure71.4Dividends paid, Q2 FY2025, three months to 2025-06-30$71.4m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-03, accession 0001492298-26-000028. Derived: 6-month figure less the 3-month figure.Report this figure71.9Dividends paid, Q3 FY2025, three months to 2025-09-30$71.9m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-05, accession 0001492298-25-000039. Derived: 9-month figure less the 6-month figure.Report this figure74.8Dividends paid, Q4 FY2025, three months to 2025-12-31$74.8m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure75.7Dividends paid, Q1 FY2026, three months to 2026-03-31$75.7m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure75.7Dividends paid, Q2 FY2026, three months to 2026-06-30$75.7m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-03, accession 0001492298-26-000028. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)252.27m, Q2 FY2026
Sabra Health Care REIT, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares231Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30230,982,227 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001492298-23-000025.Report this figure231Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31231,164,876 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001492298-24-000014.Report this figure232Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30232,244,588 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001492298-24-000025.Report this figure231Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30231,224,692 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001492298-24-000031.Report this figure233Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31233,365,031 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001492298-25-000016.Report this figure234Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30233,750,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-04, accession 0001492298-25-000031.Report this figure237Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30237,043,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure240Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31240,295,817 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure241Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30240,929,866 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure244Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30243,558,449 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure256Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31255,965,287 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure252Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30252,268,939 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure

Shares outstanding: 255.46mShares outstanding, period not labelled, at 2026-07-27255,462,756 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure at Jul 27, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.